Short-term effects of tirzepatide on weight loss in treated primary hypothyroidism: a retrospective study
Hitit Medical Journal · 29.06.2026 · 8 (2) · 296-304
DOI: 10.52827/hititmedj.1848166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hitit Medical Journal, online erschienen am 29.06.2026. Verfasst von Yusuf Elma und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Gefördert von: There are no financial funds for this article..
Abstract (Originalsprache)
Objective
This study examined whether well-controlled primary hypothyroidism treated with levothyroxine affects short-term body mass index reduction and metabolic responses to tirzepatide in adults with overweight or obesity.Material and Method: In this retrospective, single-center study, adults with overweight or obesity initiating tirzepatide were divided into two groups: individuals without thyroid disease and those with primary hypothyroidism receiving stable levothyroxine. All participants received once-weekly tirzepatide for one month along with standard lifestyle counseling. Measurements at baseline and one month included body mass index, weight, fasting blood glucose, glycated hemoglobin, thyroid-stimulating hormone, free thyroxine, and lipid parameters. Within-group changes were analyzed using paired tests, while between-group comparisons were evaluated with independent tests and repeated-measures analyses.
Results
Both groups showed significant decreases in body mass index and weight, with improvements in fasting blood glucose, glycated hemoglobin, and lipid profile. Thyroid-stimulating hormone and free thyroxine remained stable and did not differ between groups. No thyroid-related adverse events occurred. The degree of body mass index reduction was similar regardless of levothyroxine use.
Conclusion
Well-controlled primary hypothyroidism treated with levothyroxine does not reduce short-term body mass index loss or early metabolic benefits of tirzepatide, indicating that tirzepatide is effective regardless of thyroid hormone replacement.
Förderung
- There are no financial funds for this article.
Zitieren
APA
Elma, Y., & Topaloğlu, Ö. (2026). Short-term effects of tirzepatide on weight loss in treated primary hypothyroidism: a retrospective study. Hitit Medical Journal, 8(2), 296-304. https://doi.org/10.52827/hititmedj.1848166
Vancouver
Elma Y, Topaloğlu Ö. Short-term effects of tirzepatide on weight loss in treated primary hypothyroidism: a retrospective study. Hitit Medical Journal. 2026;8(2):296-304. doi:10.52827/hititmedj.1848166
BibTeX
@article{Elma2026,
author = {Elma, Yusuf and Topaloğlu, Ömercan},
title = {Short-term effects of tirzepatide on weight loss in treated primary hypothyroidism: a retrospective study},
journal = {Hitit Medical Journal},
year = {2026},
volume = {8},
number = {2},
pages = {296--304},
doi = {10.52827/hititmedj.1848166}
}
EUVIMED